Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance. | Mol Pharm | 2024 | 39166754 | PubTator, text mining | PubMed |
| Three-dimensional culture of human proximal tubular epithelial cells for an in vitro evaluation of drug-induced kidney injury. | J Pharm Sci | 2024 | 39153661 | PubTator, text mining | PubMed |
| Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol. | Rheumatology (Oxford) | 2024 | 39137147 | PubTator, text mining | PubMed |
| Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection. | Antimicrob Agents Chemother | 2024 | 39078131 | PubTator, text mining | PubMed |
| Identification of a substrate of the renal tubular transporters for detecting drug-induced early acute kidney injury. | Toxicol Sci | 2024 | 39041788 | PubTator, text mining | PubMed |
| Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters. | ACS Pharmacol Transl Sci | 2024 | 39022358 | PubTator, text mining | PubMed |
| Transporter Proteins as Therapeutic Drug Targets-With a Focus on SGLT2 Inhibitors. | Int J Mol Sci | 2024 | 39000033 | PubTator, text mining | PubMed |
| Intermittent high altitude hypoxia induced liver and kidney injury leading to hyperuricemia. | Arch Biochem Biophys | 2024 | 38944139 | PubTator, text mining | PubMed |
| The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid. | J Ethnopharmacol | 2024 | 38925319 | PubTator, text mining | PubMed |
| An in vitro-in silico workflow for predicting renal clearance of PFAS. | Toxicol Appl Pharmacol | 2024 | 38917890 | PubTator, text mining | PubMed |
| 3,3',5-Triiodothyroacetic Acid Transporters. | Thyroid | 2024 | 38836423 | PubTator, text mining | PubMed |
| Evaluation of 14 PFAS for permeability and organic anion transporter interactions: Implications for renal clearance in humans. | Chemosphere | 2024 | 38801906 | PubTator, text mining | PubMed |
| Oligomerization of drug transporters: Forms, functions, and mechanisms. | Acta Pharm Sin B | 2024 | 38799641 | PubTator, text mining | PubMed |
| Distinguishing Molecular Properties of OAT, OATP, and MRP Drug Substrates by Machine Learning. | Pharmaceutics | 2024 | 38794254 | PubTator, text mining | PubMed |
| Identification of Hyperuricemia Alleviating Peptides from Yellow Tuna Thunnus albacares. | J Agric Food Chem | 2024 | 38757561 | PubTator, text mining | PubMed |
| Magnetic quaternary ammonium polymer bearing porous agarose for selective extraction of Aristolochic acids in the plasma. | J Chromatogr A | 2024 | 38733925 | PubTator, text mining | PubMed |
| Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? | Biomed Pharmacother | 2024 | 38713940 | PubTator, text mining | PubMed |
| Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake? | Pharmaceuticals (Basel) | 2024 | 38675472 | PubTator, text mining | PubMed |
| Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors. | Chemosphere | 2024 | 38663675 | PubTator, text mining | PubMed |
| Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities. | Eur J Med Chem | 2024 | 38547733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=5